Dr. Guy Weiss, M.D
NPI: 1598084030
Total Payments
$7,718
2024 Payments
$6,706
Companies
8
Transactions
34
Medicare Patients
2,381
Medicare Billing
$290,090
Payment Breakdown by Category
Consulting$7,071 (91.6%)
Food & Beverage$646.73 (8.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,071 | 27 | 91.6% |
| Food and Beverage | $646.73 | 7 | 8.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $3,853 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,732 | 22 | $0 (2024) |
| Eli Lilly and Company | $500.00 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $249.88 | 2 | $0 (2024) |
| Ardelyx, Inc. | $148.71 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $118.73 | 1 | $0 (2023) |
| AbbVie Inc. | $97.26 | 1 | $0 (2023) |
| Laborie Medical Technologies Corp. | $18.24 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,706 | 29 | Regeneron Pharmaceuticals, Inc. ($3,853) |
| 2023 | $511.55 | 4 | Ardelyx, Inc. ($148.71) |
| 2018 | $500.00 | 1 | Eli Lilly and Company ($500.00) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $55.00 | General |
| 11/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $24.10 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $225.80 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $197.38 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $197.38 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $139.28 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $122.54 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $122.54 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $73.00 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $48.98 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $48.95 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $39.97 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $33.97 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $33.97 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $19.65 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $19.65 | General |
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $19.65 | General |
| 10/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $548.00 | General |
| 10/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $26.89 | General |
| 10/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $411.18 | General |
| 10/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $288.98 | General |
| 10/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $35.00 | General |
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $103.03 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Laborie Medical Technologies Corp. | alpHaONE (Device) | Food and Beverage | Cash or cash equivalent | $18.24 | General |
| Category: Gastroenterology | ||||||
| 09/19/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $2,094.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 508 | 552 | $716,608 | $62,027 |
| 2022 | 14 | 618 | 648 | $786,696 | $74,476 |
| 2021 | 16 | 663 | 742 | $862,039 | $82,927 |
| 2020 | 17 | 592 | 665 | $624,727 | $70,661 |
Total Patients
2,381
Total Services
2,607
Medicare Billing
$290,090
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 100 | 100 | $108,500 | $13,391 | 12.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 77 | 78 | $190,414 | $9,765 | 5.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 91 | $78,078 | $9,322 | 11.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 77 | 80 | $143,840 | $5,865 | 4.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 36 | $34,560 | $5,527 | 16.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 35 | $31,150 | $3,899 | 12.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 51 | $23,970 | $3,460 | 14.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 18 | 18 | $49,578 | $3,401 | 6.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $23,760 | $2,677 | 11.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $17,680 | $2,333 | 13.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 18 | $12,240 | $1,836 | 15.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 14 | $2,838 | $550.03 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 109 | 109 | $118,265 | $15,027 | 12.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 74 | $71,040 | $11,171 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 85 | $72,930 | $9,137 | 12.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 78 | 78 | $177,294 | $8,227 | 4.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 56 | 58 | $51,620 | $6,828 | 13.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 80 | 81 | $136,161 | $5,972 | 4.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 23 | 23 | $58,627 | $4,236 | 7.2% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2022 | 14 | 14 | $21,896 | $4,015 | 18.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $21,120 | $2,709 | 12.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 42 | $19,740 | $2,559 | 13.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $16,320 | $2,290 | 14.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $16,060 | $987.24 | 6.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 27 | 28 | $2,716 | $750.84 | 27.6% |
About Dr. Guy Weiss, M.D
Dr. Guy Weiss, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2010. The National Provider Identifier (NPI) number assigned to this provider is 1598084030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Guy Weiss, M.D has received a total of $7,718 in payments from pharmaceutical and medical device companies, with $6,706 received in 2024. These payments were reported across 34 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($7,071).
As a Medicare-enrolled provider, Weiss has provided services to 2,381 Medicare beneficiaries, totaling 2,607 services with total Medicare billing of $290,090. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Gastroenterology
- Location Buffalo, NY
- Active Since 05/24/2010
- Last Updated 08/03/2020
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1598084030
Products in Payments
- DUPIXENT (Biological) $3,972
- IBSRELA (Drug) $148.71
- STELARA (Biological) $146.85
- TREMFYA (Drug) $103.03
- RINVOQ (Biological) $97.26
- alpHaONE (Device) $18.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Buffalo
Sandra Sieminski, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $64,808
Student in an Organized Health Care Education/Training Program $64,808
Carter Lindborg, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $40,328
Student in an Organized Health Care Education/Training Program $40,328
Dr. Thomas Suchy, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $31,872
Student in an Organized Health Care Education/Training Program $31,872
Paola Ghione, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $20,368
Student in an Organized Health Care Education/Training Program $20,368
Vincent Croglio, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $15,454
Student in an Organized Health Care Education/Training Program $15,454
Steven Green, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,842
Student in an Organized Health Care Education/Training Program $13,842